FRACTYL HEALTH, INC. cotiza a 4.03 USD y tiene una capitalización bursátil de $53M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which c…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-1.41 | $-1.53 | $-0.84 |
| Estimado | $-1.49 | $-1.64 | $-1.92 | $-2.16 |
| Sorpresa | — | +14.0% | +20.3% | +61.1% |
| Métrica | GUTS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -1490.3% | -40.4% | -1449.9% |
| ROA | -116.1% | -32.0% | -84.1% |
| Current Ratio | 4.78 | 2.84 | +1.94 |
| Debt / Equity | 3.23 | 0.28 | +2.95 |